FDA regulations require that clinical trial data supporting a drug approval application be retained for two years after the application is approved, or two years after the last marketing application for the product is approved — whichever is later. In practice, this means that data from trials conducted during the development of a long-lived drug may need to be retained for fifteen years or more after the trial concluded. European regulations under EMA and individual member state requirements add further retention obligations for trials conducted in Europe, with retention periods that can extend beyond the FDA requirements. Pharmaceutical companies and the contract research organizations that run trials on their behalf generate data under these retention obligations for every trial, every site, and every patient — and the aggregate data volume from a large pharmaceutical portfolio is substantial. Storage systems that were sized and designed for active trial operations are typically not the systems that should carry that data for fifteen years.
What Clinical Trial Data Actually Looks Like at Scale
Clinical trial data is not a single file type. Electronic case report forms (eCRFs) capture patient observations, adverse event reports, and protocol deviations as structured records in clinical data management systems. Source data from laboratory information systems, imaging systems, electrocardiogram equipment, and other medical devices generates unstructured files that must be linked to the subject record they describe. Clinical trial management systems, investigational site files, and regulatory submission packages add document collections that must be retained alongside the source data they document. Audit trails — mandatory records of every change made to any clinical data record, including who made the change, when, and what the change was — must themselves be retained as immutable records.
The FDA's 21 CFR Part 11 regulation defines requirements for electronic records and electronic signatures in FDA-regulated industries, including clinical research. Part 11 requires that electronic records be maintained in a format that makes them readable throughout the required retention period, that audit trails be computer-generated and retained automatically, and that records be protected against alteration or deletion by inappropriate access. These requirements have direct storage architecture implications — a storage system that allows records to be modified after they are written does not satisfy Part 11 compliance regardless of what access controls are in place.
The ALCOA+ Framework and What It Requires From Storage
ALCOA+ is the framework that regulatory agencies use to evaluate data integrity in clinical research. Data must be Attributable (linked to the person who created it), Legible (readable in its original form), Contemporaneous (recorded at the time of the observation), Original (the first record of the data, not a copy), and Accurate (correct and consistent with the source). The "+" extensions add Complete, Consistent, Enduring, and Available to the original ALCOA attributes. These principles are not storage architecture specifications, but they define requirements that storage architecture must support.
NAS Storage platforms designed for regulated clinical environments support ALCOA+ principles through audit logging that captures access events with authenticated user identity and timestamp (Attributable, Contemporaneous), file format preservation that maintains readability over time (Legible, Enduring), write-once storage modes that prevent modification of original records (Original, Accurate), and access controls that prevent unauthorized deletion or alteration (Available, Complete). Storage platforms that do not natively support these capabilities require supplementary controls that add management complexity and create audit trail gaps that regulatory inspectors are trained to identify.
Long-Term Readability: The Problem That Arrives 10 Years After the Trial
Data that must be retained for fifteen years must also be readable at the end of that fifteen-year period. This sounds obvious but creates real problems in practice. The clinical data management system that produced the eCRF data may no longer be in production. The vendor that sold it may have been acquired or may have discontinued the product. The proprietary file format that the system used to store data may require software that is no longer available or that does not run on current operating systems. Pharmaceutical companies that retained clinical data in proprietary application formats for fifteen years have encountered situations where the data exists on the storage system but cannot be read because no software capable of reading the format is available.
A well-configured NAS System for clinical data retention stores data in formats that preserve readability independently of application software: structured data exported to standard formats like XML or CSV alongside the native application format, documents in PDF/A rather than proprietary word processor formats, and image data in standard DICOM or TIFF formats rather than device-specific formats. The storage platform's responsibility is to preserve the bits for fifteen years; the data management responsibility is to make sure those bits represent something that can be read when the retention period ends and someone needs to retrieve the data for a regulatory inquiry or litigation hold.
Immutability and the Audit Trail Chain
Clinical trial data integrity requires not just that records be retained but that any attempt to modify or delete records be recorded and prevented. An audit trail that shows a record was created, read several times over ten years, and never modified provides evidence of integrity. An audit trail with gaps — periods where the record's access history is missing — raises questions about what happened during those gaps. Storage systems that maintain continuous, unbroken audit trails for the full retention period provide the evidentiary chain that regulators require to accept electronic records as authentic.
Immutable Snapshots for NAS provide point-in-time verification of data state that complements the continuous audit trail. A snapshot taken at the close of each trial phase captures the complete state of the trial data set at that moment, providing a reference point that can be compared to the current state to detect any unauthorized modifications that might not appear in the record-level audit log. For regulatory submissions that require a sponsor to certify the integrity of submitted data, the ability to demonstrate that snapshot-preserved records are byte-for-byte identical to the current retained records provides the technical evidence supporting that certification.
Pharmaceutical organizations that treat clinical data storage as a generic IT infrastructure problem rather than a regulatory compliance architecture tend to discover the gaps during inspections — the worst possible time to find them. The storage architecture should be designed from the regulatory requirements outward: what must be retained, for how long, in what format, with what access controls, and with what audit trail. Everything else follows from those answers.
Top comments (0)